|
WO2020190977A1
|
|
Treatment of cancers using sephb4-hsa fusion proteins
|
|
WO2020168110A1
|
|
Ephb4-ephrin b2 receptor ligand pair as a novel marker for the treatment of prostate cancer
|
|
WO2012068477A1
|
|
Methods and compositions for inhibiting angiogenesis and tumor growth
|
|
US2010330152A1
|
|
Methods and compositons for antisense vegf oligonucleotides
|
|
AU2008287427A1
|
|
Cancer treatment using humanized antibodies that bind to EphB4
|
|
US2011009323A1
|
|
Non-immunoglobulin antigen binding scaffolds for inhibiting angiogenesis and tumor growth
|
|
EP2137216A2
|
|
Use of ephb4 as a diagnostic marker and a therapeutic target for ovarian cancer
|
|
EP2120996A2
|
|
Methods for using and identifying modulators of delta-like 4
|
|
US2007218061A1
|
|
Use of ephrinb2 directed agents for the treatment or prevention of viral infections
|
|
WO2007028110A2
|
|
Methods for using and identifying modulators of delta-like 4
|
|
AU2005286663A1
|
|
Compositions and methods for detecting and treating tumors
|
|
CA2581423A1
|
|
Polipeptide compounds for inhibiting angiogenesis and tumor growth
|
|
CN102746401A
|
|
Polypeptide compound for inhibiting angiogenesis and tumor growth
|
|
CA2559554A1
|
|
Polypeptide compounds for inhibiting angiogenesis and tumor growth
|
|
NZ584117A
|
|
Antibodies binding to EphB4 for inhibiting angiogenesis and tumor growth
|
|
US2005249736A1
|
|
Polypeptide compounds for inhibiting angiogenesis and tumor growth
|
|
US2005084873A1
|
|
Polypeptide compounds for inhibiting angiogenesis and tumor growth
|
